Rani Therapeutics Holdings, Inc. · NASDAQ:RANI

Imran Talat bought 35,000 Rani Therapeutics Holdings, Inc. shares (Form 4)

Traded Jul 17, 2026 · Filed Jul 21, 2026

On Jul 17, 2026, Imran Talat (Director, Chief Executive Officer) bought 35,000 Rani Therapeutics Holdings, Inc. shares at US$0.72 for US$25,200, leaving 469,736 shares. Filed Jul 21, 2026 (Form 4).

Bought
35,000 shares
Price
US$0.72
Value
US$25,200
Holding after
469,736 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 17, 2026Class A Common StockBuy35,000US$0.72469,736Direct

Source

View original at SEC

Related